STUDY OF AN ALTERNATIVE PYROGEN TEST FOR BLOOD PRODUCTS USING MONOCYTE ACTIVATION TEST.

EHA Library, Ji Hye Kim, 100184

INFILTRATION OF PLATELET RICH PLASMA OBTAINED IN OPEN SYSTEM IN PATIENTS WITH EPICONDILITIS

EHA Library, Aránzazu García Raso, 100185

COMPARISON OF IRON CHELATION EFFECTS OF DEFEROXAMINE, DEFERASIROX, AND COMBINATION OF DEFEROXAMINE AND DEFERIPRONE ON LIVER AND CARDIAC T2* MRI IN THALASSEMIA MAIOR

EHA Library, Shahla Ansari, 100186

POTENTIAL THERAPEUTIC TARGETS IN PLASMA CELL DISORDERS: A FLOW CYTOMETRY STUDY.

EHA Library, Katharina Lisenko, 100187

A CROSS-SECTIONAL STUDY COMPARING DIFFERENT HEMATOLOGICAL AND BIOCHEMICAL DISEASE MARKERS FOR CLINICAL DIAGNOSIS OF IRON DEFICIENCY

EHA Library, Dietmar Enko, 100188

DIAGNOSIS OF FUNCTIONAL IRON DEFICIENCY: HEPCIDIN AS NOVEL BIOMARKER VERSUS CONVENTIONAL CLINICAL BIOMARKERS

EHA Library, Dietmar Enko, 100189

SUPERVISED MULTI-CLASSIFIER SEPARATION OF THE PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Vibe Skov, 100190

A MODIFIED-INTERNATIONAL PROGNOSTIC INDEX INCLUDING PRETREATMENT HEMOGLOBIN LEVEL FOR EARLY STAGE EXTRANODAL NK/T CELL LYMPHOMA

EHA Library, Liang Wang, 100191

A 7- GENE SIGNATURE DEPICTS THE BIOCHEMICAL PROFILE OF EARLY PREFIBROTIC MYELOFIBROSIS

EHA Library, Vibe Skov, 100192

IPSET-THROMBOSIS BETTER IDENTIFIES THROMBOSIS FREE SURVIVAL

EHA Library, Omur Gokmen Sevindik, 100193

SOLUBLE FMS LIKE TYROSINE KINASE-1 (SFLT-1) : AN EARLY MARKER FOR GLOMERULAR DYSFUNCTION IN SICKLE CELL NEPHROPATHY

EHA Library, ILHAM YOUSSRY , 100194

IMPACT OF BURDEN OF THALASSEMIA MAJOR ON HEALTH RELATED QUALITY OF LIFE IN OMANI CHILDREN

EHA Library, Surekha Tony, 100195

BLOOD RHEOLOGY DISTURBANCES INCREASES VTE-RISK IN CHILDREN WITH ACUTE LYMPHPBLASTIC LEUKEMIA

EHA Library, Irina Kolesnikova, 100196

LONG TERM SAFETY AND ACTIVITY OF CLADRIBINE IN MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA (MALT LYMPHOMA)

EHA Library, Barbara Kiesewetter, 100197

MRI PROSPECTIVE SURVEY ON CARDIAC AND HEPATIC IRON AND CARDIAC FUNCTION IN TRANSFUSION-DEPENDENT THALASSEMIA INTERMEDIA PATIENTS TREATED WITH DESFERRIOXAMINE, DEFERIPRONE AND DEFERASIROX.

EHA Library, Alessia Pepe, 100198

SIGNIFICANT IMPROVEMENT OF SURVIVAL BY T2* MRI IN THALASSEMIA MAJOR

EHA Library, Alessia Pepe, 100199

LEFT VENTRICULAR GLOBAL FUNCTION INDEX AND LEFT VENTRICULAR MASS VOLUME RATIO BY CMR: ASSOCIATION WITH HEART FAILURE AND ARRHYTHMIAS IN THALASSEMIA MAJOR PATIENTS

EHA Library, Alessia Pepe, 100200

VPA AND SAHA TREATMENT DIFFERENTIALLY IMPACT PROTEOME AND ACETYLOME OF ACUTE MYELOID LEUKEMIA HL60 CELLS

EHA Library, Xiaoyu Zhu, 100201

STATIN ADMINISTRATION AND THE RISK FOR NON-HODGKIN LYMPHOMA: A NATIONWIDE POPULATION-BASED CASE-CONTROL STUDY

EHA Library, SHIH-FENG CHO, 100202

THROMBIN INDUCES VASCULAR LEAKAGE THROUGH MACROPHAGE MIGRATION INHIBITORY FACTOR AND AUTOPHAGY DURING SEPSIS

EHA Library, Chiao-Hsuan Chao, 100203

FEATURES OF EBV VIREMIA AND OUTCOMES IN PATIENTS RECEIVED ALLOGENEIC STEM CELL TRANSPLANTATION: A CHINESE MULTICENTER SURVEY

EHA Library, Jia Chen, 100204

BONE MINERAL DENSITY IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA

EHA Library, Sarah Farmer, 100205

THE USE OF MAGE C1 AND FLOW CYTOMETRY TO DETERMINE AND MONITOR THE MALIGNANT CELL TYPE IN MULTIPLE MYELOMA

EHA Library, Kirsty Wienand, 100206

CLINICAL SIGNIFICANCE OF CIRCULATING MICROPARTICLES IN PH- MYELOPROLIFERATIVE NEOPLASMS (MPN)

EHA Library, Yue Han, 100207

DECITABINE BRIDGING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE TREATMENT OF MDS RETROSPECTIVE EFFICACY ANALYSIS

EHA Library, Zhengzheng Fu, 100208

ORBITAL AND OCULAR ADNEXAL MALT LYMPHOMAS: A LONG-TERM OUTCOME

EHA Library, Sungwoo Park, 100209

COMPARISON BETWEEN HEALTHY DONOR-DERIVED BONE MARROW MESENCHYMAL STEM CELLS BM-MSCS AND HUMANDERMAL FIBROBLASTS: IMPACT ON CLINICAL APPLICATIONS OF HMSCS.

EHA Library, Mohammed Al Bagami, 100210

SINGLE NUCLEOTIDE POLYMORPHISMS IN APOPTOSIS PATHWAY ARE ASSOCIATED WITH RESPONSE TO IMATINIB THERAPY IN CHRONIC MYELOID LEUKEMIA

EHA Library, Jieun Uhm, 100211

SILENCING PROGRESSION OF TUMOR SUPPRESSIVE MICRORNAS ESSENTIALLY CONTRIBUTES TO DEVELOP AGGRESSIVE T-CELL LYMPHOMA

EHA Library, Akihiro Kitadate, 100212

CLINICAL SIGNIFICANCE OF THE DAY 5 PERIPHERAL BLASTS CLEARANCE RATE IN THE EVALUATION OF EARLY TREATMENT RESPONSE AND THE PROGNOSIS FOR AML PATIENTS

EHA Library, Bing Chen, 100213

RUXOLITINIB IN CHRONIC MYELOMONOCYTIC LEUKEMIA AND SYMPTOMATIC SPLENOMEGALY

EHA Library, Klaus Geissler, 100214

POMALIDOMIDE + LOW-DOSE DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL IMPAIRMENT: PHASE 1 PHARMACOKINETICS AND SAFETY

EHA Library, Jeffrey Matous, 100215

BONE MARROW-DERIVED MSCS STIMULATED BY IFN-Γ INHIBITED THE GROWTH OF TOXOPLASMA GONDII VIA UP-REGULATION OF GBP1

EHA Library, Qifa Liu, 100216

ITP PATIENTS IN THE ASIA PACIFIC: ARE THEY DIFFERENT?

EHA Library, Beng Chong, 100217

LONG-TERM RESULTS OF PREDNISONE TREATMENT FOR THE ANEMIA OF MYELOFIBROSIS

EHA Library, Juan Carlos Hernandez-Boluda, 100218

HIGH RESOLUTION MELT (HRM) CURVE ANALYSIS OF P53 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS

EHA Library, Ezzat Elhassadi, 100219

EVALUATION OF SERUM GALACTOMANNAN ASSAY FOR THE DIAGNOSIS OF INVASIVE ASPERGILLOSIS IN CHILDREN WITH HEMATOLOGICAL MALIGNANCIES

EHA Library, Ajaya Jha, 100220

AN ENDOGENOUS RETROVIRUS EXAPTATION EVENT SIGNIFICANTLY CONTRIBUTED TO THE GENERATION OF SOLUBLE RANKL MRNA: IMPLICATIONS ON THE TRANSCRIPTIONAL PROFILE OF THE TRANSCRIPT VARIANT.

EHA Library, Spyros Papamichos, 100221

PONATINIB EFFICACY AND SAFETY IN PATIENTS WITH A HISTORY OF STEM CELL TRANSPLANTATION (SCT) IN THE PACE TRIAL

EHA Library, Franck Nicolini, 100222

PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY, AND EFFICACY STUDY OF PLERIXAFOR IN CHINESE PATIENTS WITH NON-HODGKIN LYMPHOMA (NHL)

EHA Library, Huan Chen, 100223

THE INFLUENCE OF TREATMENT FACILITY VOLUME ON SURVIVAL OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Ronald Go, 100224

THE ROLE OF STEM CELL TRANSPLANTATION FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) RESISTANT TO TYROSINE KINASE INHIBITORS WITH BCR-ABL KINASE DOMAIN MUTATION T315I.

EHA Library, Julia Vlasova, 100225

A NEW MOUSE MODEL FOR MATURE B-CELL LYMPHOMA REVEALING REQUIREMENT FOR FAS DOWNREGULATION IN LYMPHOMAGENESIS

EHA Library, Eiji Sugihara, 100226

EFFICACY OF THE PAN PI3K-INHIBITOR COPANLISIB COMPARED TO SELECTIVE PI3K-Α, -Β, -Δ INHIBITORS IN MANTLE CELL LYMPHOMA (MCL)

EHA Library, Anna Zoellner, 100227

THE CLINICAL IMPLICATION OF THE ACTIVATION OF NF-ΚB SIGNALING PATHWAY IN DIFFUSE LARGE B CELL LYMPHOMA: PRE- AND POST-RITUXIMAB ERA

EHA Library, Linkun Lee, 100228

SPHINGOSINE-1-PHOSPHATE RECEPTOR 2/GQ/PHOSPHOLIPASE C AXIS IS A NOVEL MECHANISM TO OVERCOME NILOTINIB RESISTANCE IN T315I MUTATION EXPRESSING 32DCL3 MURINE CELLS

EHA Library, Aysun Adan Gökbulut, 100229

PLASMA LEVELS OF PRESEPSIN (SOLUBLE CD14-SUBTYPE) AS A NOVEL PROGNOSTIC MARKER FOR HEMOPHAGOCYTIC SYNDROME

EHA Library, Satoru Nanno, 100230

THE LYMPHOCYTE DYNAMICS PREDICTS THE BETTER RESPONSE FOR DASATINIB TREATMENT IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE

EHA Library, Yuho Najima, 100231

CLINICAL SIGNIFICANCE OF CO-EXPRESSION OF MYC AND BCL2 PROTEIN IN AGGRESSIVE B-CELL LYMPHOMAS TREATED WITH A SECOND LINE IMMUNOCHEMOTHERAPY.

EHA Library, Katsuhiro Miura, 100232

VON WILLEBRAND FACTOR DEFICIENCY CORRECTED BY LUNG TRANSPLANTATION.

EHA Library, Ana Lario, 100233

ABSOLUTE QUANTIFICATION OF EVI1 OVEREXPRESSION IN ACUTE MYELOID LEUKEMIA BY RQ-PCR ANALYSIS: A STUDY OF THE ALFA GROUP

EHA Library, Thomas Smol, 100234

OPTIMIZATION OF THERAPEUTIC DOSES OF RADOTINIB FOR CHRONIC MYELOID LEUKEMIA BASED ON EXPOSURE-RESPONSE RELATIONSHIP ANALYSES

EHA Library, Hayeon Noh, 100235

THE OUTCOMES OF HAPLOIDENTICAL HEMATOPOETIC STEM CELL TRANSPLANTATION PERFORMED WITH UNMANIPULATED DONOR STEM CELLS AND POST-TRANSPLANT CYCLOPHOSPHAMIDE IN HIGH RISK CHILDREN

EHA Library, M. Akif Yesilipek, 100236

PROPHYLACTIC USE OF SORAFENIB IN PATIENTS WITH FLT3-ITD-POSITIVE ACUTE MYELOID LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Qifa Liu, 100237

EXPRESSION OF TH17/TREGS AXIS ASSOCIATED REGULATORY FACTORS IN PATIENTS WITH ACUTE GRAFT-VERSUS-HOST DISEASE

EHA Library, Qifa Liu, 100238

THE EBMT RISK SCORE CAN PREDICT THE OUTCOME AFTER ALLOGENEIC HEMATOPOIETC CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA AMONG EGYPTIAN PATIENTS

EHA Library, Samah Desoukey, 100239

SERUM LEVELS OF FMS-LIKE TYROSINE KINASE LIGAND IN MULTIPLE MYELOMA PATIENTS ARE CORRELATED WITH MARKERS OF TUMOR PROGRSSION

EHA Library, Michael Alexandrakis, 100241

HS-TROPONINE T RELATES WITH MYOCARDIAL IRON OVERLOAD IN TRANSFUSION DEPENDENT THALASSEMIC PATIENTS

EHA Library, Calogero Vetro, 100242

THE ARROVEN STUDY (MA25101): POST-AUTHORISATION OBSERVATIONAL SAFETY STUDY OF BRENTUXIMAB VEDOTIN IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA AND SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA

EHA Library, Kim Linton, 100243

EXPRESSION OF SOXC CLUSTER AND MIR-17-92 POLYCISTRON IN MANTLE CELL LYMPHOMA PATIENTS.

EHA Library, Alejandro Roisman, 100244

PATIENTS’ PERCEPTIONS OF RECEIVING A DIAGNOSIS OF A HAEMATOLOGICAL MALIGNANCY, FOLLOWING THE SPIKES PROTOCOL

EHA Library, Lauren Dixon, 100245

FACTORS AFFECTING SURVIVAL IN PATIENTS WITH ACUTE LEUKEMIA WHO RECEIVED DONOR LYMPHOCYTE INFUSION IN THE TREATMENT OF FIRST RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Fatih Kurnaz, 100246

WHICH GUIDELINES TO TRUST? CRITICAL APPRAISAL OF CLINICAL PRACTICE GUIDELINES FOR MANTLE CELL LYMPHOMA SHOWS HIGH VARIABILITY AMONG RECOMMENDATIONS.

EHA Library, Monia Marchetti, 100247

TREATMENT WITH LOW-DOSE CYTARABINE (LD-ARAC) IN ELDERLY PATIENTS (AGE 70 YEARS OR OLDER) WITH ACUTE MYELOID LEUKEMIA (AML): A SINGLE INSTITUTION EXPERIENCE

EHA Library, Maël Heiblig, 100248

HUMAN MYELOID INHIBITORY C-LECTIN (HMICL):A NOVEL ACUTE MYELOID LEUKEMIA MARKER

EHA Library, Eman Kandeel, 100249

ARTISAN PCR: HIGHLY RELIABLE IDENTIFICATION OF FULL-LENGTH B-CELL RECEPTOR SEQUENCES

EHA Library, Marvyn Koning, 100250

ANTIPROLIFERATIVE AND APOPTOTIC EFFECTS OF PONATINIB AND ITS EFFECTS ON MACROMOLECULAR CHANGES IN IMATINIB-SENSITIVE AND –RESISTANT CHRONIC MYELOID LEUKEMIA (CML) CELL LINES: A MECHANISTIC APPROACH

EHA Library, Melis Kartal Yandim, 100251

ENDOSTEAL AND VASCULAR STRUCTURES OF BONE MARROW STROMA IN CLL

EHA Library, Natalya Semenova, 100252

ONE OUT OF FOUR TREATMENT-NAÏVE CLL PATIENTS IN TAIWAN CARRY TP53 MUTATIONS: CLINICAL AND PATHOGENETIC IMPLICATIONS

EHA Library, SHANG-JU WU, 100253

A PHASE IIA STUDY OF SINGLE-AGENT MOR208, AN FC-OPTIMIZED ANTI-CD19 ANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA

EHA Library, Wojciech Jurczak, 100254

NELARABINE IN CHILDREN WITH REFRACTORY AND RELAPSED T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Natalia Myakova, 100255

RELATIVE DOSE INTENSITY OF CHEMOTHERAPY AND PREVENTION OF FEBRILE NEUTROPENIA WITH BIOSIMILAR FILGRASTIM: A MULTICENTRIC OBSERVATIONAL STUDY OF 633 LYMPHOID MALIGNANCY PATIENTS (THE ZOHÉ STUDY).

EHA Library, Philippe Rodon, 100256

MATURATION-ASSOCIATED IMMUNOPHENOTYPIC CLASSIFICATION OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASMS

EHA Library, Julia Almeida, 100257

CARBOPLATIN, ARACTYIN PLUS DEXAMETHASONE WITH OR WITHOUT RITUXIMAB (DHAC+/-R) IS A FEASIBLE AND EFFECTIVE TREATMENT FOR LYMPHOMA PATIENTS

EHA Library, Benoit Tessoulin, 100258

FACTOR V DEFICIENCY IN WEST OF ALGERIA : SINGLE CENTER EXPERIENCE

EHA Library, Moueden Mohamed Amine, 100259

TOXICITY AND EFFICACY OF BENDAMUSTINE IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND INDOLENT LOW GRADE NON-HODGKINS LYMPHOMA (INHL); A MULTI-CENTRE OBSERVATION OF REAL LIFE EXPERIENCE IN THE UK

EHA Library, Duncan Murray, 100260

INCIDENCE OF MALIGNANCY IN ADULT PATIENTS WITH AUTOIMMUNE THROMBOCYTOPENIC PURPURA: A 12 YEAR SINGLE CENTER EXPERIENCE

EHA Library, Mahmoud Ayesh (Haj Yousef), 100261

ERYTHROCYTE-DERIVED MICROVESICLE RELEASE DURING EX-VIVO CARDIOPULMONARY BYPASS PROCEDURES

EHA Library, Rick Huisjes, 100262

CHEMOTHERAPY-INDUCED NEUROPATHY AMONG MULTIPLE MYELOMA PATIENTS AND THE INFLUENCE OF CHEMOTHERAPEUTIC AGENTS: RESULTS FROM THE POPULATION-BASED PROFILES STUDY.

EHA Library, Antoinetta Beijers, 100263

IMPACT OF NOVEL THERAPIES ON MULTIPLE MYELOMA SURVIVAL–CURRENT AND FUTURE OUTCOMES.

EHA Library, Amar Drawid, 100264

AN OBSERVATIONAL CLINICAL PRACTICE STUDY OF ROMIPLOSTIM IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA (ITP) – PLATON INTERIM RESULTS

EHA Library, Georgi Mihaylov, 100265

NILOTINIB IN JAPANESE PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) WITH SUBOPTIMAL MOLECULAR RESPONSE (MR) TO FRONTLINE IMATINIB: SENSOR FINAL 24-MO ANALYSIS AND BIM POLYMORPHISMS SUBSTUDY

EHA Library, Masafumi Taniwaki, 100266

CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III AND PRIMARY HEMOCHROMATOSIS; COEXISTENCE OF MUTATIONS IN KIF23 AND HFE.

EHA Library, Maria Liljeholm, 100267

CONCORDANCE BETWEEN CYTOLOGY AND FLOW CYTOMETRY IN THE DIAGNOSIS OF CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Isabel González-Gascón y Marín, 100268

SIL INDEX IS A SIMPLE AND OBJECTIVE PROGNOSTIC INDICATOR IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Naoto Tomita, 100269

IL-10/IL-17 DOUBLE-PRODUCING T CELLS: NEW IMMUNOSUPPRESSIVE INSIGHT IN ACUTE MYELOID LEUKEMIA

EHA Library, Silvia Carloni, 100270

THE RATIO OF LEUKOCYTE AND RED BLOOD CELL CLONES IN PATIENTS WITH AA/PNH AND THEIR CORRELATION WITH LDH LEVEL

EHA Library, Elene Shilova, 100271

A PROPOSAL OF CLASSIFICATION FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.

EHA Library, Anna Gaya, 100272

UPDATED RESULTS FROM A MULTICENTER, OPEN-LABEL, DOSE-ESCALATION PHASE 1B/2 STUDY OF SINGLE-AGENT OPROZOMIB IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, INCLUDING WALDENSTRÖM MACROGLOBULINEMIA

EHA Library, David Siegel, 100273

PREDICTIVE FACTORS TO ACHIEVE DEEP MOLECULAR RESPONSE AND LONG-TERM OUTCOMES IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS. A SINGLE CENTER EXPERIENCE IN ARGENTINA.

EHA Library, Maria Jose Mela Osorio, 100274

A STUDY OF THE MARKERS OF THROMBIN GENERATION AND INFLAMMATION IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN A SUBSET OF PATIENTS SEEN AT A TERTIARY CARE CENTRE IN NORTH INDIA

EHA Library, Rishi Dhawan, 100275

SUSTAINED INFLAMATORY CYTOKINES IN NAÏVE GAUCHER DISEASE: A LINK WITH MULTIPLE MYELOMA?

EHA Library, Marcio Miguel Andrade Campos, 100276

PROSPECTIVE STUDY OF PLASMA BIOMARKERS ASSOCIATED WITH THE INFLAMMATORY RESPONSE IN TYPE 1 GAUCHER DISEASE PATIENTS TREATED DURING ONE YEAR WITH VELAGLUCERASE ALFA.

EHA Library, Marcio Andrade-Campos, 100277

OUTCOMES OF SPLENECTOMY IN NON-HODGKIN’S LYMPHOMAS COMPLICATED BY IMMUNE CYTOPENIAS

EHA Library, Yuriy Yevstakhevych, 100278

DETECTING EARLY RELAPSE IN MULTIPLE MYELOMA AFTER ASCT: USEFULNESS OF IMMUNEASSAYS.

EHA Library, Marcio Miguel Andrade Campos, 100279

SEVERE INFECTION IN ELDERLY PATIENTS TREATED WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: ANALYSIS OF THE INTERGROUPE FRANCOPHONE DU MYÉLOME (IFM) 2009 01 PROTOCOL

EHA Library, Philippe Rodon, 100280

GRANULOCYTE COLONY-STIMULATING FACTOR INHIBITS CXCR4/SDF-1Α SIGNALING AND OVERCOMES STROMAL-MEDIATED DRUG RESISTANCE IN HL-60 CELL LINE

EHA Library, Hua Zhong, 100281

COMPARISON OF DIFFERENT COMORBIDITY INDICES FOR PREDICTING OUTCOME IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Friederike Hitz, 100282

GRANZYME B EXPRESSION IN T-REGULATORY CELLS ON DAY +14 AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT) IS A STRONG PREDICTOR OF ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD)

EHA Library, Mikhail Drokov, 100283

TUMOR GROWTH IS ASSOCIATED WITH INCREASED MCD VALUES AND TISSUE EXPRESSION OF ENDOGLIN IN MULTIPLE MYELOMA

EHA Library, Georgios Tsirakis, 100284